Targeting Interleukin-1 in Heart Disease

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2013 Oct 23

PMID 24146121

Citations 147

Authors

Benjamin W Van Tassell

Stefano Toldo

Eleonora Mezzaroma

Antonio Abbate

Affiliations

Soon will be listed here.

Citing Articles

Fermented Juice Exerts Cardioprotective Effects by Alleviating Cardiac Inflammation and Apoptosis in Rats with Lipopolysaccharide-Induced Sepsis.

Sumneang N, Kobroob A, Phungphong S, Boonhoh W, Punsawad C, Kangwan N Nutrients. 2025; 17(3).

PMID: 39940359 PMC: 11820264. DOI: 10.3390/nu17030501.

Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention?.

Cheng W, Wang Y Cells. 2025; 14(3).

PMID: 39936945 PMC: 11817712. DOI: 10.3390/cells14030153.

The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus.

Zheng R, Song W, Lu J, Yuan M, Sun X, Lu C Cardiovasc Diabetol. 2025; 24(1):63.

PMID: 39920664 PMC: 11806544. DOI: 10.1186/s12933-025-02600-3.

Synergistic combinations of for myocardial infarction treatment: network pharmacology and quadratic optimization approach.

Wang W, Fan X, Wei X, Chai W, Li F, Gao K Front Pharmacol. 2024; 15:1466208.

PMID: 39717556 PMC: 11663646. DOI: 10.3389/fphar.2024.1466208.

Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study.

Abbate A, Van Tassell B, Bogin V, Markley R, Pevzner D, Cremer P J Cardiovasc Pharmacol. 2024; 84(6):565-577.

PMID: 39642282 PMC: 11617079. DOI: 10.1097/FJC.0000000000001635.

References

Van Tassell B, Seropian I, Toldo S, Mezzaroma E, Abbate A . Interleukin-1β induces a reversible cardiomyopathy in the mouse. Inflamm Res. 2013; 62(7):637-40. DOI: 10.1007/s00011-013-0625-0. View

Crossman D, Morton A, Gunn J, Greenwood J, Hall A, Fox K . Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study). Trials. 2008; 9:8. PMC: 2289802. DOI: 10.1186/1745-6215-9-8. View

Mezzaroma E, Toldo S, Abbate A . Role of NLRP3 (cryopyrin) in acute myocardial infarction. Cardiovasc Res. 2013; 99(1):225-6. DOI: 10.1093/cvr/cvt123. View

Fisher Jr C, Agosti J, Opal S, Lowry S, Balk R, Sadoff J . Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med. 1996; 334(26):1697-702. DOI: 10.1056/NEJM199606273342603. View

Sandanger O, Ranheim T, Vinge L, Bliksoen M, Alfsnes K, Finsen A . The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res. 2013; 99(1):164-74. DOI: 10.1093/cvr/cvt091. View

Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo J . Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996; 183(3):949-58. PMC: 2192364. DOI: 10.1084/jem.183.3.949. View

Schmid M, Avraamides C, Dippold H, Franco I, Foubert P, Ellies L . Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression. Cancer Cell. 2011; 19(6):715-27. PMC: 3144144. DOI: 10.1016/j.ccr.2011.04.016. View

Abbate A, Biondi-Zoccai G, Baldi A . Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol. 2002; 193(2):145-53. DOI: 10.1002/jcp.10174. View

Abbate A, Van Tassell B, Seropian I, Toldo S, Robati R, Varma A . Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse. Eur J Heart Fail. 2010; 12(4):319-22. DOI: 10.1093/eurjhf/hfq017. View

10.

Grothusen C, Hagemann A, Attmann T, Braesen J, Broch O, Cremer J . Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia/reperfusion injury. ScientificWorldJournal. 2012; 2012:737585. PMC: 3354588. DOI: 10.1100/2012/737585. View

11.

Abbate A, Salloum F, Van Tassell B, Vecile E, Toldo S, Seropian I . Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. PLoS One. 2011; 6(11):e27923. PMC: 3225370. DOI: 10.1371/journal.pone.0027923. View

12.

Owyang A, Maedler K, Gross L, Yin J, Esposito L, Shu L . XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model. Endocrinology. 2010; 151(6):2515-27. DOI: 10.1210/en.2009-1124. View

13.

A Crackower M, Oudit G, Kozieradzki I, Sarao R, Sun H, Sasaki T . Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell. 2002; 110(6):737-49. DOI: 10.1016/s0092-8674(02)00969-8. View

14.

Abbate A, Van Tassell B, Biondi-Zoccai G . Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. BioDrugs. 2012; 26(4):217-33. DOI: 10.1007/BF03261881. View

15.

Strowig T, Henao-Mejia J, Elinav E, Flavell R . Inflammasomes in health and disease. Nature. 2012; 481(7381):278-86. DOI: 10.1038/nature10759. View

16.

Bevilacqua M, Pober J, Majeau G, COTRAN R, Gimbrone Jr M . Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984; 160(2):618-23. PMC: 2187463. DOI: 10.1084/jem.160.2.618. View

17.

Salloum F, Chau V, Varma A, Hoke N, Toldo S, Biondi-Zoccai G . Anakinra in experimental acute myocardial infarction--does dosage or duration of treatment matter?. Cardiovasc Drugs Ther. 2008; 23(2):129-35. DOI: 10.1007/s10557-008-6154-3. View

18.

Wang X, Takagawa J, Lam V, Haddad D, Tobler D, Mok P . Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response. Sci Transl Med. 2011; 3(100):100ra90. PMC: 3350804. DOI: 10.1126/scitranslmed.3002814. View

19.

Shinkai K, McCalmont T, Leslie K . Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol. 2007; 33(1):1-9. DOI: 10.1111/j.1365-2230.2007.02540.x. View

20.

Saitoh T, Kishida H, Tsukada Y, Fukuma Y, Sano J, Yasutake M . Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris. J Am Coll Cardiol. 2000; 35(3):655-65. DOI: 10.1016/s0735-1097(99)00583-5. View